The new year marks a new era: Somite is now Cellular Intelligence. This is a statement of what we are building: the first universal virtual cell signaling-model to understand, predict, and control cell behavior. To mark this moment, we’re releasing a white paper sharing

Cellular Intelligence is building the first universal virtual cell-signaling model. Read our recent white paper to learn how we’ve progressed from concept to demonstrating in vitro and in silico proof-of-concept results, all in less than two years: https://t.co/MLW5A8YxxF cc

Cellular Intelligence Unveils with “AlphaFold Vision” for AI-Driven Cell Therapy Formerly Somite AI, the rebranded company aims to broaden the #regenerativemedicine landscape by building AI models that engineer cell fate @MichaBreakstone #AI #celltherapy https://t.co/ZuosqIYwO0

Somite is now Cellular Intelligence. More than a rebrand, this reflects what our team has been building over the last two years: the first universal virtual cell signaling model, designed to understand, predict, and ultimately control cell behavior. To further mark this step

2026 won’t just be about better drugs, it will be about better engines for discovering, building, and scaling biology itself. I shared my predictions on where venture investment in biotech is headed in @stephaniemehta's latest @FastCompany piece. Read the full article here:

Our Head of Computational Biology, @arjunrajlab, joined @AnushElangovan of @AMD and @upstageai's Head of US at #AWSreInvent to discuss how to accelerate AI workloads with AMD-powered solutions. Thank you Arjun for sharing how we utilize and scale AI to develop next-generation

We presented at the @officialbiohub Affiliate Symposium in NYC, where one theme kept coming up: building AI that can truly model cellular behavior will require high-quality, large-scale data and AI-native tools. At Somite, this is exactly what we’re focused on.

Our VP of Strategy, @SamanthaDStrass, joined the @scverse_team conference to share our work on building a virtual cell signaling model rooted in human development. The engagement that followed was incredible. Excited to keep pushing the field forward.

Congratulations to our Scientific Co-founder @JShendure on being elected to the @theNAMedicine🙌 Jay’s work in genomics—from pioneering exome sequencing to developing innovative lineage-recording tools—continues to inspire our mission at Somite. #Biotech #TechBio #Genomics

Our Co-Founder & CEO, @MichaBreakstone, and VP of Strategy, @SamanthaDStrass, sat down with @davidwild77 on @Citeline’s In Vivo podcast to dive into how Somite is generating datasets that will reshape regenerative medicine. Check out the full convo here:

Exploring the Future of Cell Therapy with Olivier Pourquié! Olivier brings his deep expertise in developmental biology to Somite. In his talk, he highlighted his lab’s progress in developing satellite cell protocols that could unlock new treatments for neuromuscular diseases. He

It’s been a remarkable summer at Somite: our labs and offices have been overflowing with scientific energy. We’ve had the privilege of hosting Olivier Pourquié (@harvardmed) , Allon Klein (@harvardmed, @KleinLabHMS), and Arjun Raj (@upenn, @arjunrajlab) on sabbatical - each

@SomiteAi × AMD Ventures: Boosting Compute to Reimagine Cell Therapies! Thrilled to announce a strategic investment from @AMD Ventures, following our Series A led by @KhoslaVentures. Pairing our data engine with AMD Instinct GPUs helps build the compute stack for the next

Somite named one of Israel’s 15 most promising startups for 2025! 🚀 Huge thanks to @TheMarker for the recognition - past honorees include unicorns like @Hailo_ai , @Gong_io, @Papaya_Global, & @viz_ai. Click below for the full story 👇

Catch the energy of our recent Boston lab-warming and Series A celebration. Our CEO @MichaBreakstone shares a highlights video capturing Somite's vision for the future of medicine. Watch below! #AI #StemCells #FutureOfMedicine #Boston

Single-cell transcriptomics depth rivals breadth for foundation model performance - Somite will see you at ICML 2025! We’re excited to present new findings on how biological noise, especially single-cell transcriptomics depth, shapes the performance of single-cell foundation

Read more in @Forbes:

Somite is building the blueprints to create any cell type for any person. We call it DeltaStem, our foundation model for the human cell. Our proprietary capsule technology allows us to generate cell signaling data 1,000x faster and more efficiently than current methods,